All financings
COMPANY TRANSACTIONS

Virax Biolabs Group Ltd.

VRAXNasdaqBiotechnology

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES

Deal notes

ContextDeal context

This is an ATM facility event. The capacity shown is not cash raised.

Gross proceedsNo cash proceeds
Offering price—
Discount to prior close—
Warrant coverage—

Transaction overview

01

Virax Biolabs Group Ltd disclosed an at-the-market program event: facility amended. Available capacity is $2.1M. This event does not record cash proceeds raised.

Financing type
ATM
Announcement date
—
SEC disclosure date
Sep 4, 2026
Agreement date
Jan 22, 2024
Pricing date
—
Closing date
—
Filing date
Sep 4, 2026
Status
Amended
Market cap before SEC disclosure
$1.0M
Prior closing price
$2.56
Raise as % of market cap
—

Market data · FMP

Historical market cap
$1,017,830.4
Market date
Sep 3, 2026
Closing price
$2.56
Latest reported shares outstanding
19,923,431
Latest reported float shares
19,566,104
Share-data date
Oct 1, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 1, 2026.

Financial Modeling Prep ↗

Financing terms

02

At-the-market program

Capital event
Facility amended
Available capacity
$2.1M
Proceeds raised
Not reported as raised
Shares sold
—
Average sale price
—
Relevant period
Not applicable
Sales commission
—

Fees & transaction economics

03
Placement agent / underwriting fee
—
Agent fee amount
—
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

424B5 · Virax Biolabs Group LtdSEC filing · Sep 4, 2026
Open source ↗
FMP historical market data · VRAXMarket data · Sep 3, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.